ERYKINE 40000IU INJECTION 1ML belongs to a class of drugs known as erythropoiesis-stimulating agent (ESA) primarily used to treat anaemia (lack of haemoglobin in blood) due to chronic kidney disease and anaemia due to chemotherapy (cancer treatment). Anaemia is reduced levels of haemoglobin and red blood cells (RBCs) in the blood. Chronic kidney disease (CKD) patients slowly develop anaemia, which gets worse as the disease progresses. Also, the treatment of cancer, including chemotherapy and radiotherapy, causes anaemia in cancer patients.

ERYKINE 40000IU INJECTION 1ML contains ‘Erythropoietin alfa, human recombinant’. ERYKINE 40000IU INJECTION 1ML works by stimulating the bone marrow (soft tissue within the bones that makes red blood cells) to make more red blood cells. This ERYKINE 40000IU INJECTION 1ML is very similar to the natural substance in the body known as erythropoietin (hormone formed by kidneys and produced RBC), preventing anaemia (lack of haemoglobin and RBC in the blood).

ERYKINE 40000IU INJECTION 1ML will be administered by a healthcare professional; do not self-administer. You may experience high blood pressure, nausea, vomiting and fever. Most of these side effects of ERYKINE 40000IU INJECTION 1ML do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are known to be allergic to ERYKINE 40000IU INJECTION 1ML or any other medicines, please tell your doctor. ERYKINE 40000IU INJECTION 1ML should not be taken in conditions like heart disease, high blood pressure, or liver disease. If you are pregnant or a nursing mother, it is advised to consult a doctor before using ERYKINE 40000IU INJECTION 1ML. ERYKINE 40000IU INJECTION 1ML may affect your ability to drive and use machines as ERYKINE 40000IU INJECTION 1ML may cause fits disorder during the first 90 days of treatment. 

ERYKINE 40000IU INJECTION 1ML helps in the treatment of anemia which may happen due to chronic kidney disease and cancer chemotherapy. ERYKINE 40000IU INJECTION 1ML works by stimulating the bone marrow (soft tissue within the bones that makes red blood cells) to make more red blood cells. This ERYKINE 40000IU INJECTION 1ML is very similar to the natural substance in the body known as erythropoietin (hormone formed by kidneys and produced RBC) which prevents anemia (lack of hemoglobin and RBC in the blood). Besides this ERYKINE 40000IU INJECTION 1ML is also used for the treatment of anemia caused by a medicine known as zidovudine for the treatment of HIV (human immunodeficiency viruses). ERYKINE 40000IU INJECTION 1ML also decreases the requirement for blood cell transfusions.

If you are known to be allergic to ERYKINE 40000IU INJECTION 1ML or any other medicines, please tell your doctor. ERYKINE 40000IU INJECTION 1ML should not be taken in conditions like high blood pressure, heart disease, heart attack, blood clot in the brain (stroke), fits disorder, liver disease, or kidney disease. Before taking ERYKINE 40000IU INJECTION 1ML inform your doctor if you have any type of cancer or skin reactions. If you are pregnant or a nursing mother, it is advised to consult a doctor before using ERYKINE 40000IU INJECTION 1ML. ERYKINE 40000IU INJECTION 1ML may affect your ability to drive and using machines as ERYKINE 40000IU INJECTION 1ML may cause fits to disorder during the first 90 days of treatment. ERYKINE 40000IU INJECTION 1ML should not be used for children below 1 month of age during treatment of anemia due to chronic kidney disease. ERYKINE 40000IU INJECTION 1ML should not be used for children below 5 years of age during treatment of anemia due to chemotherapy.